The Omicron variant: Threat or no threat?
This week saw investors trying to assess the threat of the omicron variant. The variant seems to be more transmissible, but is it more deadly? Do existing vaccines work? If so, how well? These are some of the key questions. One thing to remember is that the latest variant fears broke over the US Thanksgiving, a lower liquidity session, so any moves were likely to be exacerbated by this. If markets are reassured that the omicron variant is not as much of a threat as initially feared, then expect a retracement higher in oil, risk pairs like the NZDJPY, and stocks.
Other key events from the past week
-
JPY: Recent weakness unwound, Nov 29: The JPY and the CHF found strong bids to start the week on fears over the new omicron variant. If these fears are unfounded watch out for a sharp snap higher in the NZDJPY pair as the RBNZ have recently revised their interest rate expectations higher.
-
USD: Dollar strength, Nov 30: The USD found some strength midweek as Jerome Powell suggested that it is a good time to retire the ‘transitory’ reference for inflation. This boosted the USD midweek on faster Fed taper expectations.
-
US oil: Omicron fears hit price, Dec 01: Oil markets fell heavily at the start of the week as fears that a vaccine-resistant omicron virus would smash oil demand once again. If the omicron variant is actually found to be countered by existing vaccines, then watch out for a sharp snap back higher in oil.
Key events for the coming week
-
AUD: Interest Rate Meeting, Dec 07: The last RBA decision was ‘hawkish indeed, but dovish in word’. Will the RBA bring forward rate hikes from 2024 in their meeting next week? Perhaps asset bubbles will concern them?
-
Seasonal trades, NZDJPY: Swing trade? Dec 06: NZDJPY has some strong seasonals heading into December. Also, if the omicron variant fears fade, the risk pair should move higher. Check out the strong seasonal pattern here.
-
CAD: Interest Rate Meeting, Dec 08: The last Bank of Canada meeting saw a hawkish shift from the BoC. There was an early end to QE and an earlier rate hike projection, but will the omicron variant give them a reason to be more dovish?
Author
Giles Coghlan LLB, Lth, MA
Financial Source
Giles is the chief market analyst for Financial Source. His goal is to help you find simple, high-conviction fundamental trade opportunities. He has regular media presentations being featured in National and International Press.
